Analysts Offer Insights on NA Companies: Exponent (EXPO) and Generac Holdings (GNRC)

Analysts from William Blair and Stifel Nicolaus maintained Buy ratings on Exponent (EXPO) and Generac Holdings (GNRC) respectively. EXPO has a Strong Buy consensus and $84.00 price target, while GNRC has a Moderate Buy consensus and $295.79 price target, reflecting a 42.3% upside. Both stocks closed at $64.53 and $212.22 last Tuesday.

Original reporting
Published Oct 1, 2026, 11:05 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 12:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Analysts Offer Insights on NA Companies: Exponent (EXPO) and Generac Holdings (GNRC) — source image
Decision brief

The 30-second read

$EXPOBullishLow
01

Why it matters

Analyst upgrades may prompt short-term buying interest but lack fresh company-specific catalysts.

02

Market read

Analyst sentiment shift could modestly influence stock prices, but no new corporate events are disclosed.

03

What to watch

No new fundamental data; price targets rely on assumptions not disclosed.

Relevance 4/10Novelty 3/10Timing: today

Background

The article aggregates recent analyst opinions on Exponent and Generac, providing updated ratings and price targets.

Company-level read

Ticker impact

$EXPOBullishMedium confidence
Context

Analyst Andrew Nicholas maintains a Buy rating on Exponent and sets a $84 price target.

Expected impact

likely upward pressure as investors price in the higher target.

Evidence & confidence

Buy rating and $84 target suggest upside from current $64.53 close.

$GNRCBullishMedium confidence
Context

Stifel Nicolaus analyst Stephen Gengaro reiterates a Buy rating on Generac and sets a $290 price target.

Expected impact

likely upward pressure as market absorbs the higher target.

Evidence & confidence

Buy rating and $290 target indicate upside from current $212.22 close.

Market effects

Positive sentiment for the NA sector as two analysts issue bullish views.

May lift broader US market sentiment in the near term.

Limited to US-listed peers.

Counterpoint

Ratings could be premature if earnings miss expectations.

Key entities

  • Andrew Nicholas

    William Blair analyst covering Exponent.

  • Stephen Gengaro

    Stifel Nicolaus analyst covering Generac.

Related articles

$GNRCMedAI 8/10

Generac Holdings Inc (GNRC) Q3 2026 Earnings Call Highlights: Record

Generac Holdings Inc (GNRC) reported Q3 2026 earnings with record net sales of $1.29B, up 16% YoY, and adjusted EBITDA of $256M, up 33%. The company secured a $2.4B supply agreement with Amazon for data center backup generators, boosting backlog to $4.5B. Residential segment sales grew 9%, while industrial and telecom channels faced challenges. Gross margin is expected to moderate to 37-38% in Q4 due to sales mix and inflation.

$EXPOMedAI 8/10

What Exponent (EXPO) Said on Its Q3 Earnings Call

Exponent (EXPO) reported $171M in stock buybacks over the past year, reducing shares outstanding by 5%. Q3 saw $14.7M in dividends. Revenue grew 13% in engineering, 3% in environmental/health. AI-related work is 15-20% of business. Q4 outlook: 8-10% revenue growth, 26.3-26.8% EBITDA margin. Full-year 2026 outlook raised: 10-11% revenue growth, 28-28.3% EBITDA margin.